Q4 2024 Hypera SA Earnings Call Transcript

Mar 21, 2025 / 02:00 PM GMT

Release Date Price: €2.72 (-1.45%)

Transcript

Key Points

Positve

Hypera SA (HYPMY) achieved a 9% increase in sellout for 2024, with significant growth in the institutional non-retail market at 26%.
The company successfully launched over 50 new products in 2024, enhancing its product portfolio across various categories including consumer health and skincare.
Hypera SA (HYPMY) invested over 2.3 billion in marketing, innovation, and production capacity, demonstrating a strong commitment to growth and innovation.
The company was recognized for its sustainable practices and corporate governance, being included in the FTSE for good and the S&P Global sustainability yearbook.
Hypera SA (HYPMY) posted the highest operational cash flow in its history, exceeding 2.5 billion Brazilian reals, benefiting from working capital optimization.

Negative

Net revenue for 2024 decreased by 6% compared to 2023, attributed to the working capital optimization process.
Operational income was reduced due to lower operational leverage and a mix of products sold with lower margins.
The company's EBITDA margin from continuing operations was 28%, with a significant reduction in net income from continuing operations by 19% for the year.
Hypera SA (HYPMY) faced increased competition in the generics market, impacting pricing strategies and market share.
The working capital optimization strategy, while beneficial in the long term, resulted in short-term pain and reduced sales in the short term.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HYPE3.SA - Hypera SA
Q4 2024 Hypera SA Earnings Call
Mar 21, 2025 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning ladies and gentlemen. Welcome to Beta Pharma's earnings call for the 4th quarter of 2024.

We have with us Mr. Bruno Oliveira, CEO Ramon Silva, CFO, and Addo Mario Coto, IRO.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
This event is being recorded.

--------------------------------------------------------------------------------
Unidentified_1 [3]
--------------------------------------------------------------------------------
The video can be seen at the company's investor relations website, RI. IEA.com.p.

We would also like to inform you that

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.